吉祥坊登录

Shanghai, China – Shanghai MicroPort Endovascular MedTech Co., Ltd. (“Endovastec™”) was recently awarded the “Pudong New Area Quality Gold Prize” (“the Prize”) after a panel announced the results of the panel review and public inputs done for the 3rd Pudong New Area Government Quality Prizes.

Pudong New Area Government Quality Prizes comprised the Head of Pudong New Area Quality Prize, the Prize and Quality Innovation Prize. The Prize is mainly awarded to the benchmark and model entities that show outstanding quality management achievements and leading economic and social contributions in Pudong New Area. This selection is based on the "Pudong New Area Government Quality Award Management Measures" and "Excellent Performance Evaluation Criteria". It aims to create an open, innovative and high-quality Pudong, further enhance Pudong's overall quality level and urban core competitiveness, and set a quality benchmark for society.

The selection for the 3rd Pudong New Area Government Quality Prizes started in December 2018 and lasted almost a year. In accordance with the principles of science, objectivity, and fairness, the Office of the Evaluation Committee conducts rigorous evaluations in all rounds, including qualification evaluation, qualification evaluation, on-site evaluation, comprehensive evaluation, and review of the plenary meeting of the evaluation committee, social publicity, which mainly evaluating companies in the performance of leadership, strategy, customers and markets, resources, process management, measurement, analysis and improvement, and results in management. This evaluation lasts for one year. Finally, Endovastec™ beat the other companies and was awarded the Prize for its outstanding general operations and management ability as well as performance in the areas of innovation ability, quality management, social responsibility, and corporate culture.

Endovastec™ always adheres to giving top priority to quality and preference to profit, and has developed a comprehensive quality management model in which corporate culture and quality management measures are integrated with excellent performance management. Endovastec™ has built a high-quality team and achieved comprehensive increases in product quality, process quality, service quality and business quality.

The pursuit of excellence is endless and has a long way to go. In the future, Endovastec™ will continue to follow thedevelopment strategy of “intelligent manufacturing in China”, and take the “Qualtiy-led and Innovation-driven” path, making unremitting efforts to build into a world-leading high-tech company in the field of aorta and peripheral vascular as soon as possible through way of growing good to great, keeping the ingenuity spirit forever, creating a national brand. Ultimately Endovastec™ contribute for Shanghai to build a globally influential technology innovation center and an internationally competitive high-quality place.